Shrydus Industries Ltd
₹ 2.99
-8.56%
27 Feb
- close price
About
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
Key Points
- Market Cap ₹ 9.57 Cr.
- Current Price ₹ 2.99
- High / Low ₹ 7.00 / 2.85
- Stock P/E
- Book Value ₹ 13.3
- Dividend Yield 0.00 %
- ROCE 2.52 %
- ROE 3.00 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.22 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -2.81% over past five years.
- Promoter holding is low: 25.9%
- Company has a low return on equity of 5.24% over last 3 years.
- Company has high debtors of 308 days.
- Promoter holding has decreased over last 3 years: -13.8%
- Working capital days have increased from 391 days to 929 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.01 | 0.44 | 0.27 | 0.23 | 0.00 | 5.20 | 2.48 | 9.00 | 9.29 | 9.45 | 4.51 | 0.20 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| 0.17 | 1.34 | 0.59 | 0.38 | 0.24 | 2.45 | 5.25 | 2.75 | 8.94 | 9.02 | 8.93 | 3.76 | 2.70 | |
| Financing Profit | -0.15 | -1.33 | -0.15 | -0.11 | -0.01 | -2.45 | -0.05 | -0.27 | 0.06 | 0.27 | 0.52 | 0.74 | -2.50 |
| Financing Margin % | -750.00% | -13,300.00% | -34.09% | -40.74% | -4.35% | -0.96% | -10.89% | 0.67% | 2.91% | 5.50% | 16.41% | -1,250.00% | |
| 0.01 | 1.35 | -0.01 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 | |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.15 | 0.02 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.06 | 0.29 | 0.52 | 0.74 | -2.49 |
| Tax % | 0.00% | -450.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | -3.45% | 0.00% | 0.00% | |
| -0.15 | 0.11 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.04 | 0.30 | 0.52 | 0.73 | -2.00 | |
| EPS in Rs | -0.06 | 0.05 | -0.07 | -0.05 | -0.00 | -0.99 | -0.02 | -0.11 | 0.02 | 0.12 | 0.16 | 0.23 | -0.63 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 84% |
| 5 Years: | -3% |
| 3 Years: | -21% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 75% |
| 3 Years: | 163% |
| TTM: | -173% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 16% |
| 3 Years: | -52% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 4% |
| 3 Years: | 5% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.66 | 12.01 | 32.02 | 32.02 |
| Reserves | -5.52 | -5.41 | -5.58 | -5.68 | -5.69 | -8.08 | -8.12 | -8.39 | -8.35 | -7.75 | -6.05 | 10.70 | 10.60 |
| Borrowing | 0.33 | 0.01 | 0.35 | 0.01 | 0.06 | 0.00 | 0.02 | 0.24 | 1.72 | 1.86 | 10.91 | 0.02 | 0.02 |
| 0.62 | 0.51 | 0.55 | 0.52 | 0.53 | 0.02 | 5.15 | 2.57 | 2.27 | 3.14 | 0.02 | 0.02 | 0.02 | |
| Total Liabilities | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 | 42.66 |
| 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.84 | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| 2.57 | 4.08 | 4.30 | 3.83 | 3.88 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.74 | 42.64 | |
| Total Assets | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 | 42.66 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.12 | -3.49 | 0.25 | 0.07 | 0.04 | -0.40 | 0.13 | -0.31 | -1.51 | -0.15 | -13.46 | -25.14 | |
| -0.01 | 4.17 | -0.40 | -0.29 | -0.09 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | |
| 0.13 | -0.32 | 0.35 | -0.34 | 0.05 | -0.55 | 0.02 | 0.22 | 1.48 | 1.04 | 12.58 | 25.13 | |
| Net Cash Flow | 0.00 | 0.35 | 0.20 | -0.56 | 0.00 | -0.03 | 0.15 | -0.09 | -0.03 | 0.88 | -0.88 | -0.03 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | -4.15% | -33.94% | -4.21% | -3.21% | -0.30% | -112.18% | -5.21% | -33.54% | 5.80% | 22.90% | 13.21% | 3.00% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Feb - Newspaper publication for unaudited financial result for the quarter ended December 31, 2025
- Unaudited Standalone And Consolidated Financial Result For The Quarter And Nine Months Ended December 31, 2025 13 Feb
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th February, 2026
13 Feb - Unaudited standalone and consolidated Q3 and nine-month results ended Dec 31, 2025; limited review.
-
Board Meeting Intimation for Consider And Approve The Unaudited Financial Result For The Quarter Ended December 31, 2025
6 Feb - Board meeting on 13 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jan - Certificate under SEBI Reg 74(5) for quarter ended 31 Dec 2025 from RTA Skyline.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector